Goode Paul has filed 12 insider transactions across 1 company since June 2024.
Most recent transaction: a transaction of 42 shares of Glucotrack, Inc. ($GCTK) on March 25, 2025.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2025 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | J | Common Stock, par value $0.001 per share | 42 | $0.00 | 339.0000 | 0 | 14.14% | 0.00% |
| Feb. 5, 2025 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | J | Common Stock, par value $0.001 per share | 1500 | $0.00 | 3,554.0000 | 0 | 73.03% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | X | Common Stock, par value $0.001 per share | 15435 | $0.00 | 18,989.0000 | 0 | 434.30% | 0.00% |
| June 14, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | A | Stock option (right to buy) | 3277 | $0.00 | 3,277.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | P | Warrants to Purchase Common Stock | 2100 | $0.00 | 2,100.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | P | Convertible Promissory Note | 10000 | $10000.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | C | Common Stock, par value $0.001 per share | 796 | $31.20 | 2,054.0000 | 0 | 63.28% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | A | Series A Common Warrant | 796 | $0.00 | 796.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | A | Series B Common Warrant | 796 | $0.00 | 796.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | X | Series B Common Warrant | 796 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | C | Convertible Promissory Note | 24831 | $24831.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 1, 2024 | Glucotrack, Inc. | $GCTK | Goode Paul | Chief Executive Officer | P | Warrants to Purchase Common Stock | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |